Literature DB >> 21261

Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amphetamine in the rat.

R Samanin, A Jori, S Bernasconi, E Morpugo, S Garattini.   

Abstract

The pharmacological activities of amineptine (S 1694) and (+)-amphetamine and their interaction with biogenic amines have been examined in rats. The locomotor activity, stereotyped behaviour and hypothermia induced by amineptine were similar to but not as marked as those produced by (+)-amphetamine, and there was little or no anorectic action. Amineptine does not modify the concentrations of brain noradrenaline or acetylcholine which are respectively reduced and increased by (+)-amphetamine. Moreover, amineptine does not affect significantly the decrease of brain noradrenaline induced by an intraventricular injection of 6-hydroxydopamine, an effect significantly antagonized by (+)-amphetamine. On the other hand, like amphetamine, amineptine significantly reduces the effect of 6-hydroxy-dopamine on brain dopamine. Both drugs increase the striatal concentrations of homovanillic acid and show a cross tolerance in this action. Therefore they could act similarly on the striatal dopaminergine system. Amineptine thus appears to be a new type of antidepressant with a brain biochemical profile differing from that of other drugs used in depressive disorders.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21261     DOI: 10.1111/j.2042-7158.1977.tb11395.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  13 in total

1.  [Sleep changes induced by chronic administration of S. 1694 (Survector) (author's transl)].

Authors:  E Balzamo; G Vuillon-Cacciuttolo
Journal:  Psychopharmacology (Berl)       Date:  1977-12-28       Impact factor: 4.530

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 3.  Is the forced swimming test a suitable model for revealing antidepressant activity?

Authors:  F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Pharmacokinetics of amineptine in man.

Authors:  C Sbarra; M G Castelli; A Noseda; R Fanelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

5.  Evidence that the dorsal raphe area is involved in the effect of clonidine against pentylenetetrazole-induced seizures in rats.

Authors:  M Lazarova; C Bendotti; R Samanin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

6.  Use of potentiation of thyrotrophin releasing hormone (TRH)-induced hyperthermia as a test for screening antidepressants which activate alpha-adrenoceptor systems.

Authors:  M Desiles; R Rips
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

7.  Electrophysiological effects of amineptine on neurones of the rat substantia nigra pars compacta: evidence for an inhibition of the dopamine uptake system.

Authors:  N B Mercuri; F Stratta; P Calabresi; G Bernardi
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

Review 8.  Treatment for amphetamine withdrawal.

Authors:  Steven J Shoptaw; Uyen Kao; Keith Heinzerling; Walter Ling
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

9.  Effect of long term amineptine treatment on pre- and postsynaptic mechanisms in rat brain.

Authors:  A Ceci; S Garattini; M Gobbi; T Mennini
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

10.  The role of different types of adrenergic receptors in pentylenetetrazol-induced seizures and the effect of di-n-propylacetate in the rat.

Authors:  M Lazarova; C Bendotti; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.